Additional layers of complexity and uncertainty continue to be added to how life sciences companies bring their products to market as more stakeholders become involved in the commercialization process. While much emphasis is placed on company compliance with regulatory requirements – less emphasis has been placed on vendors or global commercial partners. By not having an established auditing, monitoring and surveillance program of third parties, an undue amount of risk and uncertainty can be imposed on drug manufacturers and their products.
Join us for an informative presentation about drug safety governance when working with third parties. Our colleagues will discuss:
There are no prerequisites for this webinar, and advance preparation is not required. There is no cost to attend this webinar.
CPE credit: One (1) hour total credit
Field of study: Management Advisory Services
A certificate of completion will be emailed to you four to six weeks after the event.
For more information regarding administrative policies such as complaint and refund, please contact our offices at +1 (608) 240 2522.
Baker Tilly US, LLP is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: learningmarket.org.